المؤلفون: Martino M; Stem Cell Transplantation and Cellular Therapies Unit (CTMO), Grande Ospedale Metropolitano 'Bianchi-Melacrino-Morelli', Reggio Calabria, Italy., Gamberi B; Azienda USL - IRCCS di Reggio Emilia, Reggio Emilia, Reggio Emilia, Italy., Antonioli E; Hematology Department, Careggi Hospital, Florence, Italy., Aquino S; Hematology and Hematopoietic Stem Cell Transplantation Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy., Della Pepa R; Hematology Unit, Department of Clinical Medicine and Surgery, University of Naples 'Federico II', Naples, Italy., Malerba L; Haematology and Haematopoietic Stem Cell Transplant Center, AST, Pesaro Urbino, Pesaro, Italy., Mangiacavalli S; Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Pezzatti S; Department of Haematology, San Gerardo Hospital, Monza, MB, Italy., Bringhen S; SSD Clinical trial in oncoematologia e mieloma multiplo, Dipartimento di Oncologia, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy., Zamagni E; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy.; Dipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, Bologna, Italy.

المصدر: Expert review of hematology [Expert Rev Hematol] 2024 Jul; Vol. 17 (7), pp. 375-390. Date of Electronic Publication: 2024 May 21.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101485942 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1747-4094 (Electronic) Linking ISSN: 17474094 NLM ISO Abbreviation: Expert Rev Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Bispecific*/therapeutic use , Immunotherapy, Adoptive*/methods , Immunotherapy, Adoptive*/adverse effects , Multiple Myeloma*/therapy , Multiple Myeloma*/immunology , B-Cell Maturation Antigen*/immunology , B-Cell Maturation Antigen*/antagonists & inhibitors, Humans ; Receptors, Chimeric Antigen/immunology ; Receptors, Chimeric Antigen/therapeutic use ; Immunotherapy/methods ; T-Lymphocytes/immunology

المؤلفون: Yang Y; Department of Hematology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China., Qin S; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Peking University International Cancer Institute, Peking University Health Science Center, Beijing, China., Yang M; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Peking University International Cancer Institute, Peking University Health Science Center, Beijing, China., Wang T; Department of Hematology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China., Feng R; Department of Hematology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China., Zhang C; Department of Hematology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China., Zheng E; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Peking University International Cancer Institute, Peking University Health Science Center, Beijing, China., Li Q; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Peking University International Cancer Institute, Peking University Health Science Center, Beijing, China., Xiang P; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Peking University International Cancer Institute, Peking University Health Science Center, Beijing, China., Ning S; Department of Hematology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China., Xu X; Department of Hematology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China., Zuo X; Department of Hematology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China., Zhang S; Department of Hematology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China., Yun X; Department of Hematology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China., Zhou X; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Peking University International Cancer Institute, Peking University Health Science Center, Beijing, China., Wang Y; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, China., He L; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Peking University International Cancer Institute, Peking University Health Science Center, Beijing, China.; Department of Integration of Chinese and Western Medicine, School of Basic Medical Sciences, State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University Health Science Center, Beijing, China., Shang Y; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Peking University International Cancer Institute, Peking University Health Science Center, Beijing, China.; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, China., Sun L; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Peking University International Cancer Institute, Peking University Health Science Center, Beijing, China.; Department of Integration of Chinese and Western Medicine, School of Basic Medical Sciences, State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University Health Science Center, Beijing, China., Liu H; Department of Hematology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Sep 13; Vol. 30 (18), pp. 4201-4214.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Multiple Myeloma*/therapy , Multiple Myeloma*/immunology , Multiple Myeloma*/pathology , B-Cell Maturation Antigen*/immunology , B-Cell Maturation Antigen*/genetics , Tumor Microenvironment*/immunology , Immunotherapy, Adoptive*/methods , Receptors, Chimeric Antigen*/immunology , Receptors, Chimeric Antigen*/genetics, Humans ; Female ; Lymphocyte Depletion ; Middle Aged ; Male ; CD8-Positive T-Lymphocytes/immunology ; CD8-Positive T-Lymphocytes/metabolism ; Aged

المؤلفون: Hagen M; Friedrich Alexander University Erlangen-Nuremberg , Erlangen, Germany., Bucci L; Friedrich Alexander University Erlangen-Nuremberg , Erlangen, Germany., Böltz S; Friedrich Alexander University Erlangen-Nuremberg , Erlangen, Germany., Nöthling DM; Friedrich Alexander University Erlangen-Nuremberg , Erlangen, Germany., Rothe T; Friedrich Alexander University Erlangen-Nuremberg , Erlangen, Germany., Anoshkin K; Friedrich Alexander University Erlangen-Nuremberg , Erlangen, Germany., Raimondo MG; Friedrich Alexander University Erlangen-Nuremberg , Erlangen, Germany., Tur C; Friedrich Alexander University Erlangen-Nuremberg , Erlangen, Germany., Wirsching A; Friedrich Alexander University Erlangen-Nuremberg , Erlangen, Germany., Wacker J; Friedrich Alexander University Erlangen-Nuremberg , Erlangen, Germany., Düsing C; Heinrich Heine University Düsseldorf, Düsseldorf, Germany., Distler JHW; Heinrich Heine University Düsseldorf, Düsseldorf, Germany., Kuwert T; Friedrich Alexander University Erlangen-Nuremberg , Erlangen, Germany ricardo.grieshaber@fau.de., Bozec A; Friedrich Alexander University Erlangen-Nuremberg , Erlangen, Germany ricardo.grieshaber@fau.de., Ramming A; Friedrich Alexander University Erlangen-Nuremberg , Erlangen, Germany ricardo.grieshaber@fau.de., Schett G; Friedrich Alexander University Erlangen-Nuremberg , Erlangen, Germany ricardo.grieshaber@fau.de., Grieshaber-Bouyer R; Friedrich Alexander University Erlangen-Nuremberg , Erlangen, Germany ricardo.grieshaber@fau.de.

المصدر: The New England journal of medicine [N Engl J Med] 2024 Sep 05; Vol. 391 (9), pp. 867-869.

نوع المنشور: Letter

بيانات الدورية: Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE

مواضيع طبية MeSH: Autoimmune Diseases*/drug therapy , Autoimmune Diseases*/immunology , B-Cell Maturation Antigen*/immunology , B-Cell Maturation Antigen*/antagonists & inhibitors , T-Lymphocytes*/drug effects , T-Lymphocytes*/immunology , Immunosuppressive Agents*/administration & dosage , Immunosuppressive Agents*/adverse effects, Humans ; Antibodies, Bispecific/administration & dosage ; Female ; Adult ; Middle Aged ; Treatment Outcome

المؤلفون: Alexander T; Charité-Universitätsmedizin Berlin, Berlin, Germany., Krönke J; Charité-Universitätsmedizin Berlin, Berlin, Germany., Cheng Q; Charité-Universitätsmedizin Berlin, Berlin, Germany., Keller U; Charité-Universitätsmedizin Berlin, Berlin, Germany., Krönke G; Charité-Universitätsmedizin Berlin, Berlin, Germany.

المصدر: The New England journal of medicine [N Engl J Med] 2024 Sep 05; Vol. 391 (9), pp. 864-866.

نوع المنشور: Case Reports; Letter

بيانات الدورية: Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE

مواضيع طبية MeSH: B-Cell Maturation Antigen*/antagonists & inhibitors , B-Cell Maturation Antigen*/immunology , Immunosuppressive Agents*/administration & dosage , Lupus Erythematosus, Systemic*/complications , Lupus Erythematosus, Systemic*/drug therapy , Lupus Erythematosus, Systemic*/immunology , Remission Induction*/methods, Adult ; Female ; Humans ; Antibodies, Bispecific/administration & dosage ; Antibodies, Monoclonal, Humanized/administration & dosage ; Drug Resistance ; Injections, Subcutaneous

المؤلفون: Qiang W; Department of Hematology, Myeloma & Lymphoma Center, Shanghai Changzheng Hospital, Shanghai, China., Lu J; Department of Hematology, Myeloma & Lymphoma Center, Shanghai Changzheng Hospital, Shanghai, China., Jia Y; Department of Hematology, Myeloma & Lymphoma Center, Shanghai Changzheng Hospital, Shanghai, China., Liu J; Gracell Biotechnologies Ltd, Shanghai, China., Liu J; Department of Hematology, Myeloma & Lymphoma Center, Shanghai Changzheng Hospital, Shanghai, China., He H; Department of Hematology, Myeloma & Lymphoma Center, Shanghai Changzheng Hospital, Shanghai, China., Wang X; Department of Hematology, Myeloma & Lymphoma Center, Shanghai Changzheng Hospital, Shanghai, China., Fan X; Department of Hematology, Myeloma & Lymphoma Center, Shanghai Changzheng Hospital, Shanghai, China., Jin L; Department of Hematology, Myeloma & Lymphoma Center, Shanghai Changzheng Hospital, Shanghai, China., Ruan Q; Department of Hematology, Myeloma & Lymphoma Center, Shanghai Changzheng Hospital, Shanghai, China., Zhang Q; Gracell Biotechnologies Ltd, Shanghai, China., Shen L; Gracell Biotechnologies Ltd, Shanghai, China., Weng L; Gracell Biotechnologies Ltd, Shanghai, China., Cao W; Gracell Biotechnologies Ltd, Shanghai, China., Li W; Gracell Biotechnologies Ltd, Shanghai, China., Du J; Department of Hematology, Myeloma & Lymphoma Center, Shanghai Changzheng Hospital, Shanghai, China.

المصدر: JAMA oncology [JAMA Oncol] 2024 Sep 01; Vol. 10 (9), pp. 1259-1263.

نوع المنشور: Journal Article; Clinical Trial, Phase I

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Multiple Myeloma*/therapy , Multiple Myeloma*/immunology , Multiple Myeloma*/drug therapy , B-Cell Maturation Antigen*/antagonists & inhibitors , B-Cell Maturation Antigen*/immunology , Antigens, CD19*/immunology , Antigens, CD19*/therapeutic use, Humans ; Male ; Middle Aged ; Female ; Aged ; Immunotherapy, Adoptive/adverse effects ; Immunotherapy, Adoptive/methods ; Adult ; Receptors, Chimeric Antigen/therapeutic use ; Receptors, Chimeric Antigen/immunology ; Treatment Outcome

المؤلفون: Tan MSY; Department of Haematology, Singapore General Hospital, Singapore.; Department of Haematology, National Cancer Centre Singapore, Singapore., Chen Y; Department of Haematology, Singapore General Hospital, Singapore.; Department of Haematology, National Cancer Centre Singapore, Singapore., Smith EL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.

المصدر: Blood advances [Blood Adv] 2024 Aug 27; Vol. 8 (16), pp. 4433-4446.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Multiple Myeloma*/therapy , Multiple Myeloma*/immunology , B-Cell Maturation Antigen*/antagonists & inhibitors , B-Cell Maturation Antigen*/immunology, Humans ; Immunotherapy/methods ; Molecular Targeted Therapy ; T-Lymphocytes/immunology ; T-Lymphocytes/metabolism ; Signaling Lymphocytic Activation Molecule Family/antagonists & inhibitors ; Signaling Lymphocytic Activation Molecule Family/immunology ; Signaling Lymphocytic Activation Molecule Family/metabolism

المؤلفون: Guo P; Department of Hematology, Myeloma and Lymphoma Center, Shanghai Changzheng Hospital, Naval Medical University, Shanghai, China., Wang Y; Department of Hematologic Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China., He H; Department of Hematology, Myeloma and Lymphoma Center, Shanghai Changzheng Hospital, Naval Medical University, Shanghai, China., Chen D; Department of Hematology, Myeloma and Lymphoma Center, Shanghai Changzheng Hospital, Naval Medical University, Shanghai, China., Liu J; Department of Hematology, Myeloma and Lymphoma Center, Shanghai Changzheng Hospital, Naval Medical University, Shanghai, China., Qiang W; Department of Hematology, Myeloma and Lymphoma Center, Shanghai Changzheng Hospital, Naval Medical University, Shanghai, China., Lu J; Department of Hematology, Myeloma and Lymphoma Center, Shanghai Changzheng Hospital, Naval Medical University, Shanghai, China., Liang Y; Department of Hematologic Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China., Du J; Department of Hematology, Myeloma and Lymphoma Center, Shanghai Changzheng Hospital, Naval Medical University, Shanghai, China.

المصدر: Clinical and experimental immunology [Clin Exp Immunol] 2024 Aug 09; Vol. 217 (3), pp. 221-232.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 0057202 Publication Model: Print Cited Medium: Internet ISSN: 1365-2249 (Electronic) Linking ISSN: 00099104 NLM ISO Abbreviation: Clin Exp Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Multiple Myeloma*/blood , Multiple Myeloma*/immunology , Multiple Myeloma*/diagnosis , B-Cell Maturation Antigen*/blood , B-Cell Maturation Antigen*/immunology , Biomarkers, Tumor*/blood, Humans ; Male ; Female ; Prognosis ; Middle Aged ; Aged ; Adult ; Aged, 80 and over ; Luminescent Measurements/methods

المؤلفون: Neri P; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada., Leblay N; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada., Lee H; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada., Gulla A; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Turin, Italy., Bahlis NJ; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada., Anderson KC; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Kenneth_Anderson@dfci.harvard.edu.

المصدر: Nature reviews. Clinical oncology [Nat Rev Clin Oncol] 2024 Aug; Vol. 21 (8), pp. 590-609. Date of Electronic Publication: 2024 Jul 03.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101500077 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1759-4782 (Electronic) Linking ISSN: 17594774 NLM ISO Abbreviation: Nat Rev Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Multiple Myeloma*/immunology , Multiple Myeloma*/therapy , Multiple Myeloma*/drug therapy , B-Cell Maturation Antigen*/immunology , B-Cell Maturation Antigen*/antagonists & inhibitors , Receptors, G-Protein-Coupled*/immunology , Receptors, G-Protein-Coupled*/metabolism, Humans ; Immunotherapy/methods ; Receptors, Fc/immunology ; Molecular Targeted Therapy/methods ; Membrane Proteins/immunology

المؤلفون: Firestone RS; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Socci ND; Department of Engineering and Bioinformatics, Memorial Sloan Kettering Cancer Center, New York, NY., Shekarkhand T; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Zhu M; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Qin WG; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Hultcrantz M; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Medicine, Weill Cornell Medical College, New York, NY., Mailankody S; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Medicine, Weill Cornell Medical College, New York, NY.; Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Tan CR; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Medicine, Weill Cornell Medical College, New York, NY., Korde N; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Medicine, Weill Cornell Medical College, New York, NY., Lesokhin AM; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Medicine, Weill Cornell Medical College, New York, NY.; Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Hassoun H; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Medicine, Weill Cornell Medical College, New York, NY., Shah U; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Medicine, Weill Cornell Medical College, New York, NY., Maclachlan KH; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Medicine, Weill Cornell Medical College, New York, NY., Rajeeve S; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Medicine, Weill Cornell Medical College, New York, NY.; Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Landau HJ; Department of Medicine, Weill Cornell Medical College, New York, NY.; Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Scordo M; Department of Medicine, Weill Cornell Medical College, New York, NY.; Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Shah GL; Department of Medicine, Weill Cornell Medical College, New York, NY.; Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Lahoud OB; Department of Medicine, Weill Cornell Medical College, New York, NY.; Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Giralt S; Department of Medicine, Weill Cornell Medical College, New York, NY.; Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Murata K; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Usmani SZ; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Medicine, Weill Cornell Medical College, New York, NY.; Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Chung DJ; Department of Medicine, Weill Cornell Medical College, New York, NY.; Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.

المصدر: Blood [Blood] 2024 Jul 25; Vol. 144 (4), pp. 402-407.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

مواضيع طبية MeSH: Multiple Myeloma*/immunology , Multiple Myeloma*/drug therapy , Multiple Myeloma*/genetics , Multiple Myeloma*/pathology , Multiple Myeloma*/therapy , B-Cell Maturation Antigen*/genetics , B-Cell Maturation Antigen*/immunology , Drug Resistance, Neoplasm*, Humans ; Male ; Female ; Middle Aged ; Antibodies, Bispecific/therapeutic use ; Aged ; Antibodies, Monoclonal, Humanized

المؤلفون: Eslami M; Department of Immunobiology, University of Lausanne, Epalinges 1066, Switzerland., Schuepbach-Mallepell S; Department of Immunobiology, University of Lausanne, Epalinges 1066, Switzerland., Diana D; Department of Immunobiology, University of Lausanne, Epalinges 1066, Switzerland., Willen L; Department of Immunobiology, University of Lausanne, Epalinges 1066, Switzerland., Kowalczyk-Quintas C; Department of Immunobiology, University of Lausanne, Epalinges 1066, Switzerland., Desponds C; Department of Immunobiology, University of Lausanne, Epalinges 1066, Switzerland., Peter B; Department of Immunobiology, University of Lausanne, Epalinges 1066, Switzerland., Vigolo M; Department of Immunobiology, University of Lausanne, Epalinges 1066, Switzerland., Renevey F; Department of Immunobiology, University of Lausanne, Epalinges 1066, Switzerland., Donzé O; AdipoGen Life Sciences, Epalinges 1066, Switzerland., Luther SA; Department of Immunobiology, University of Lausanne, Epalinges 1066, Switzerland., Yalkinoglu Ö; Clinical Pharmacology, Global Early Development, The Healthcare Business of Merck KGaA, Darmstadt 64293, Germany., Alouche N; Department of Immunobiology, University of Lausanne, Epalinges 1066, Switzerland., Schneider P; Department of Immunobiology, University of Lausanne, Epalinges 1066, Switzerland.

المصدر: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2024 Jul 16; Vol. 121 (29), pp. e2404309121. Date of Electronic Publication: 2024 Jul 11.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1091-6490 (Electronic) Linking ISSN: 00278424 NLM ISO Abbreviation: Proc Natl Acad Sci U S A Subsets: MEDLINE

مواضيع طبية MeSH: B-Cell Activating Factor*/immunology , B-Cell Activating Factor*/metabolism , B-Cell Activating Factor*/genetics , Tumor Necrosis Factor Ligand Superfamily Member 13*/metabolism , Tumor Necrosis Factor Ligand Superfamily Member 13*/immunology , Tumor Necrosis Factor Ligand Superfamily Member 13*/genetics , B-Cell Maturation Antigen*/immunology , B-Cell Maturation Antigen*/metabolism , Transmembrane Activator and CAML Interactor Protein*/metabolism , Transmembrane Activator and CAML Interactor Protein*/genetics , Transmembrane Activator and CAML Interactor Protein*/immunology , Interleukin-6*/metabolism , Interleukin-6*/immunology , B-Cell Activation Factor Receptor*/metabolism , B-Cell Activation Factor Receptor*/immunology , B-Cell Activation Factor Receptor*/genetics, Animals ; Mice ; Plasma Cells/immunology ; Plasma Cells/metabolism ; Mice, Knockout ; Antibody-Producing Cells/immunology ; Antibody-Producing Cells/metabolism ; Mice, Inbred C57BL